Therefore, Tα1 + PCDs treatments seem to establish a balance between the cytotoxic effects of CD8+ T cells and Treg, potentially playing a beneficial role in acute HCMV infection or reinfection [47,48]. The gene discussed is CD8A; the disease is cytomegalovirus infection.